TABLE 1:
Patient Demographics
| Inactive n = 100 |
Active n = 137 |
P value | |
|---|---|---|---|
| Age (years ± SD; range) | 23 ± 17 (4-67) | 28 ± 17 (5-71) | 0.07 |
| Male (%) | 64.0% | 69.3% | |
| White (%) | 95.0% | 92.7% | |
| EDP Score * | 332 ± 83 | 123 ± 136 | < 0.0001 |
| Peak Eosinophil Count (eosinophils/HPF) | 3 ± 4 | 50 ± 34 | < 0.0001 |
| Atopic Status | |||
| Allergic Rhinitis (%) | 44.0% | 38.7% | |
| Asthma (%) | 24.0% | 25.5% | |
| Eczema (%) | 26.0% | 24.1% | |
| Food Allergy (%) | 42.0% | 40.9% | |
| Ongoing Diet Therapy (%) | 50.0% | 51.1% | |
| Current PPI Usage (%) | 34.0% | 39.4% | |
| Current Oral Systemic Steroids (%) | 0% | 0% | |
| Current Swallowed Topical Steroids (%) | 59.0% | 47.4% | |
| History of Steroid Usage (%) | 68.0% | 71.5% | |
| Response to Steroid – Symptom (% Effective) | 73.5% | 63.3% | |
| Response to Steroid – Pathology (% Effective) | 64.7% | 51.0% |
*
EDP score calculated as the sum of delta Ct values.